Pulse Biosciences (Nasdaq:PLSE) today announced the enrollment of the first patient in its NANOCLAMP AF study for treating ...

Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel nPulse™ technology using its proprietary Nanosecond ...

Q3 2025 Earnings Call Transcript October 23, 2025 Roper Technologies, Inc. beats earnings expectations. Reported EPS is $5.14 ...